Pacira Pharmaceuticals, Inc.

10578 Science Center Drive
Suite 125
San Diego, CA 92121
(858) 625 2424

5 Sylvan Way
Parsippany, NJ 07054
(973) 254 3560

TAKING CARE OF PATIENTS, TODAY AND TOMORROW

SEC Filings

10-K
PACIRA PHARMACEUTICALS, INC. filed this Form 10-K on 03/01/2017
Entire Document
 << Previous Page | Next Page >>

EXHIBIT INDEX
Exhibit
Number
 
Description
3.1

 
 
Amended and Restated Certificate of Incorporation of the Registrant.(1)
3.2

 
 
Amended and Restated Bylaws of the Registrant.(1)
4.1

 
 
Specimen Certificate evidencing shares of common stock.(2)
4.2

 
 
Indenture (including form of Notes), dated January 23, 2013, between the Registrant and Wells Fargo Bank, National Association, as trustee.(3)
10.1

 
 
Second Amended and Restated 2007 Stock Option/Stock Issuance Plan.(2)***
10.2

 
 
Form of Stock Option Agreement under the Second Amended and Restated 2007 Stock Option/Stock Issuance Plan.(2)***
10.3

 
 
Investors’ Rights Agreement, dated March 23, 2007, among the Registrant and the parties named therein.(2)
10.4

 
 
Assignment Agreement, dated February 9, 1994, amended April 15, 2004, between the Registrant and Research Development Foundation.(2)
10.5

 
 
Stock Purchase Agreement, dated January 8, 2007, between SkyePharma, Inc. and the Registrant.(2)
10.6

 
 
Supply Agreement, dated June 30, 2003, between SkyePharma, Inc. and Mundipharma Medical Company.(2)
10.7

 
 
Distribution Agreement, dated June 30, 2003, between SkyePharma, Inc. and Mundipharma International Holdings Limited.(2)
10.8

 
 
Distribution Agreement, dated July 27, 2005, between SkyePharma, Inc. and Mundipharma International Holdings Limited.(2)
10.9

 
 
DepoCyt Supply and Distribution Agreement, dated December 31, 2002, between SkyePharma, Inc. and Enzon Pharmaceuticals, Inc.(2)
10.10

 
 
Industrial Real Estate Triple Net Lease, dated August 17, 1993, between the Registrant and HCP TPSP, LLC.(2)
10.11

 
 
Fifth Amendment, dated March 13, 2013, to the Industrial Real Estate Triple Net Lease, dated August 17, 1993, between the Registrant and HCP TPSP, LLC (and successor-in-interest to Equitable Life Assurance Society of the United States).(4)
10.12

 
 
Industrial Real Estate Lease, dated December 8, 1994, amended July 2, 2009, between the Registrant and LASDK Limited Partnership.(2)
10.13

 
 
Third Amendment, dated March 13, 2013, to the Industrial Real Estate Lease, dated December 8, 1994, between the Registrant and LASDK Limited Partnership.(4)
10.14

 
 
Employment Agreement between the Registrant and David Stack.(2)***
10.15

 
 
Amendment No. 1 to Executive Employment Agreement, dated March 13, 2013, between the Registrant and David Stack.(4)***
10.16

 
 
Amendment No. 2 to Executive Employment Agreement, dated June 30, 2015, between the Registrant and David Stack.(14)***
10.17

 
 
Employment Agreement between the Registrant and James Scibetta.(2)***
10.18

 
 
Amendment No. 1 to Executive Employment Agreement, dated March 13, 2013, between the Registrant and James Scibetta.(4)***
10.19

 
 
Amendment No. 2 to Executive Employment Agreement, dated June 30, 2015, between the Registrant and James Scibetta.(14)***
10.20

 
 
Employment Agreement, dated November 29, 2012, between the Registrant and Kristen Williams.(13)***
10.21

 
 
Amendment No. 1 to Employment Agreement, dated March 13, 2013, between the Registrant and Kristen Williams.(13)***
10.22

 
 
Amendment No. 2 to Employment Agreement, dated June 30, 2015, between the Registrant and Kristen Williams.(14)***
10.23

 
 
Executive Employment Agreement, dated May 2, 2016, between the Registrant and Charles A. Reinhart, III.(17)***
10.24

 
 
Executive Employment Agreement, dated June 11, 2015, between the Registrant and Scott Braunstein.(16)***
10.25

 
 
Executive Employment Agreement, dated August 24, 2015, between the Registrant and James Jones.(16)***
10.26

 
 
Form of Warrant to purchase common stock of the Registrant, dated January 22, 2009.(2)
10.27

 
 
Form of Warrant to purchase common stock of the Registrant, dated December 29, 2010.(2)
10.28

 
 
Form of Indemnification Agreement between the Registrant and its directors and officers.(2)***
10.29†

 
 
Commercial Outsourcing Services Agreement entered into as of August 25, 2011 by the Registrant and Integrated Commercialization Solutions, Inc.(5)


 << Previous Page | Next Page >>

Contact Investor Relations:
Susan Mesco
(973) 451-4030
Susan.Mesco@pacira.com


IHI/NPSF Project Seeks to Improve the Assessment and Management of Acute Pain
Click here for more...